Logo image of BH

BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

USA - NYSE:BH - US08986R3093 - Common Stock

316.8 USD
-4.23 (-1.32%)
Last: 11/14/2025, 8:04:00 PM
316.8 USD
0 (0%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, BH scores 4 out of 10 in our fundamental rating. BH was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. BH has an excellent financial health rating, but there are some minor concerns on its profitability. BH is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BH had positive earnings in the past year.
In the past year BH had a positive cash flow from operations.
In multiple years BH reported negative net income over the last 5 years.
In the past 5 years BH always reported a positive cash flow from operatings.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

BH has a better Return On Assets (4.57%) than 65.15% of its industry peers.
The Return On Equity of BH (6.70%) is better than 61.36% of its industry peers.
With a Return On Invested Capital value of 2.23%, BH is not doing good in the industry: 68.94% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for BH is significantly below the industry average of 10.59%.
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROIC 2.23%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

BH's Profit Margin of 10.47% is fine compared to the rest of the industry. BH outperforms 77.27% of its industry peers.
The Operating Margin of BH (5.21%) is worse than 62.88% of its industry peers.
In the last couple of years the Operating Margin of BH has grown nicely.
Looking at the Gross Margin, with a value of 38.13%, BH is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of BH has grown nicely.
Industry RankSector Rank
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BH is destroying value.
The number of shares outstanding for BH remains at a similar level compared to 1 year ago.
BH has less shares outstanding than it did 5 years ago.
BH has a worse debt/assets ratio than last year.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

BH has an Altman-Z score of 3.21. This indicates that BH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.21, BH is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
BH has a debt to FCF ratio of 1.42. This is a very positive value and a sign of high solvency as it would only need 1.42 years to pay back of all of its debts.
BH's Debt to FCF ratio of 1.42 is amongst the best of the industry. BH outperforms 87.88% of its industry peers.
BH has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.14, BH belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Altman-Z 3.21
ROIC/WACC0.27
WACC8.28%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.38 indicates that BH should not have too much problems paying its short term obligations.
BH has a better Current ratio (1.38) than 67.42% of its industry peers.
A Quick Ratio of 1.35 indicates that BH should not have too much problems paying its short term obligations.
BH has a better Quick ratio (1.35) than 69.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.35
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 210.98% over the past year.
The Revenue has been growing slightly by 4.14% in the past year.
Measured over the past years, BH shows a very negative growth in Revenue. The Revenue has been decreasing by -11.55% on average per year.
EPS 1Y (TTM)210.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%213.5%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.36, the valuation of BH can be described as very cheap.
Based on the Price/Earnings ratio, BH is valued cheaply inside the industry as 98.48% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BH to the average of the S&P500 Index (25.89), we can say BH is valued rather cheaply.
Industry RankSector Rank
PE 4.36
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

67.42% of the companies in the same industry are more expensive than BH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BH is valued cheaper than 88.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.65
EV/EBITDA 9
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BH!.
Industry RankSector Rank
Dividend Yield N/A

BIGLARI HOLDINGS INC-B

NYSE:BH (11/14/2025, 8:04:00 PM)

After market: 316.8 0 (0%)

316.8

-4.23 (-1.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06
Earnings (Next)02-27 2026-02-27
Inst Owners88.79%
Inst Owner Change3.46%
Ins Owners0.4%
Ins Owner Change0%
Market Cap722.30M
Revenue(TTM)377.18M
Net Income(TTM)39.51M
Analysts43.33
Price TargetN/A
Short Float %30.33%
Short Ratio3.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.36
Fwd PE N/A
P/S 1.92
P/FCF 11.65
P/OCF 8.34
P/B 1.23
P/tB 1.41
EV/EBITDA 9
EPS(TTM)72.68
EY22.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)27.19
FCFY8.58%
OCF(TTM)37.98
OCFY11.99%
SpS165.43
BVpS258.46
TBVpS225.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number650.12
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROCE 2.67%
ROIC 2.23%
ROICexc 2.72%
ROICexgc 3.1%
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
FCFM 16.44%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexgc growth 3Y-14.08%
ROICexgc growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Debt/EBITDA 1.34
Cap/Depr 59.46%
Cap/Sales 6.52%
Interest Coverage 250
Cash Conversion 141.88%
Profit Quality 156.94%
Current Ratio 1.38
Quick Ratio 1.35
Altman-Z 3.21
F-Score5
WACC8.28%
ROIC/WACC0.27
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)210.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%213.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.96%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.73%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y-30.77%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%

BIGLARI HOLDINGS INC-B / BH FAQ

What is the fundamental rating for BH stock?

ChartMill assigns a fundamental rating of 4 / 10 to BH.


What is the valuation status of BIGLARI HOLDINGS INC-B (BH) stock?

ChartMill assigns a valuation rating of 5 / 10 to BIGLARI HOLDINGS INC-B (BH). This can be considered as Fairly Valued.


How profitable is BIGLARI HOLDINGS INC-B (BH) stock?

BIGLARI HOLDINGS INC-B (BH) has a profitability rating of 4 / 10.


What is the valuation of BIGLARI HOLDINGS INC-B based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIGLARI HOLDINGS INC-B (BH) is 4.36 and the Price/Book (PB) ratio is 1.23.